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Background: To determine the effect of different imaging options and the most efficient imaging strategy for
treatment planning of patients with hip prostheses.
Methods: The planning kilovoltage CT (kVCT) and daily megavoltage CT (MVCT) studies for three prostate cancer
patients with bilateral hip prostheses were used for creating hybrid kVCT/MVCT image sets. Treatment plans were
created for kVCT images alone, hybrid kVCT/MVCT images, and MVCT images alone using the same dose
prescription and planning parameters. The resulting dose volume histograms were compared. The orthopedic
metal artifact reduction (O-MAR) reconstruction tool for kVCT images and different MVCT options were investigated
with a water tank fit with double hip prostheses. Treatment plans were created for all imaging options and
calculated dose was compared with the one measured by a pin-point ion chamber.
Results: On average for three patients, the D35% for the bladder was 8% higher in plans based on MVCT images
and 7% higher in plans based on hybrid images, compared to the plans based on kVCT images alone. Likewise, the
D35% for the rectum was 3% higher than the kVCT based plan for both hybrid and MVCT plans. The average
difference in planned D99% in the PTV compared to kVCT plans was 0.9% and 0.1% for MVCT and hybrid plans,
respectively. For the water tank with hip prostheses phantom, the kVCT plan with O-MAR correction applied
showed better agreement between the measured and calculated dose than the original image set, with a
difference of −1.9% compared to 3.3%. The measured doses for the MVCT plans were lower than the calculated
dose due to image size limitations. The best agreement was for the kVCT/MVCT hybrid plans with the difference
between calculated and measured dose around 1%.
Conclusion: MVCT image provides better visualization of patient anatomy and hybrid kVCT/MVCT study enables
more accurate calculations using updated MVCT relative electron density calibration.
Keywords: Tomotherapy, MVCT, ProsthesesIntroduction
As the population ages, the number of patients present-
ing for radiotherapy with hip prostheses is expected to
increase. According to the Canadian Joint Replacement
Registry (CJRR), in 2006–07 there were 24,253 hip re-
placement surgeries performed in Canada, up 60.2%
from 1996–97 [1]. The hip prostheses are typically made
of high atomic number materials producing severe arti-
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stated.computed tomography (kVCT) images. These artifacts
prevent accurate contour delineation and alter image
density values required for accurate dose calculation.
Recent advances in imaging include newer CT recon-
struction algorithms to minimize artifacts from CT im-
aging. In addition, cone beam and fan beam megavoltage
CT images are available on treatment units. Images ac-
quired at these energies are less subject to imaging arti-
facts as the primary mode of interaction at megavoltage
energies is Compton (dependent on electron density)
instead of photoelectric effects (dependent mainly on
cube of atomic number) seen with kilovoltage energies.
Magnetic resonance imaging (MRI) is often used inral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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contours due to its better soft tissue resolution [2].
A significant amount of research has been performed on
methods to reduce image artifacts in kVCT images.
Wang et al. proposed a fast iterative algorithm that utilizes
intermediate reconstruction to improve image quality [3]
and Zhang et al. suggested pre-processing projection data
for application in cone-beam CT images [4]. These tools
are now routinely available for clinical use on CT-
Simulators. For example, the CT-Simulator used at our
institution incorporates an orthopedic metal artifact
reduction (termed O-MAR) tool (Philips Healthcare,
Andover, MA). O-MAR may be applied to kVCT scans
when the patient has high density metal implants [5].
Recently, it has been shown that metal artifacts are signifi-
cantly reduced by imaging patients with a megavoltage
CT (MVCT) scanner [6-8]. Theoretically, MVCT images
can also be used for dose calculation in the presence of
high atomic number materials such as hip prostheses [9].
Helical tomotherapy (HT) is a relatively new approach
in radiation treatment of cancer patients [10]. HT com-
bines intensity-modulated helical radiation treatment de-
livery with a 6 MV beam and CT imaging with 3.5 MV
x-rays to deliver precise image-guided treatment plans.
MVCT is currently used to register patient positioning
prior to treatment and to verify dose delivery by recalcu-
lating the dose distribution using fluence and the MVCT
image set of the same day. Linear accelerators incorporat-
ing cone-beam CT capability (MVision, Siemens Medical
Solution, Concord, CA) also have the potential to acquire
MVCT images [11].
It is the aim of this paper to determine the most effect-
ive treatment planning strategy for patients with bilateral
hip prostheses in terms of accurate dose calculation and
delivery. Different planning options were analyzed using
the imaging data for three patients and a specially de-
signed phantom. The strategies considered include: using
kVCT images alone, with or without a correction algo-
rithm (O-MAR) applied; using hybrid kVCT and MVCT
images, and using MVCT images alone for treatment
planning.
Materials and methods
Effect of imaging modality on patient treatment plan
Three prostate cancer patients with bilateral hip pros-
theses treated on an HT unit at the London Regional
Cancer Program, London, Ontario, Canada were used
for this study. The patients were immobilized using a
conventional double-leg immobilization device [12] and
were instructed to empty their bladder and drink 400 ml
of water one hour before the treatment and try to empty
their bowels. The patients initially underwent imaging
on pelvis protocol (120 kVp, 50 mA) with 3 mm inter-
slice spacing on a 16-slice helical kVCT simulator(Brilliance Big Bore; Philips Healthcare, Andover, MA).
The presence of strong artifacts in the pelvic region due
to the hip prostheses made reliable target contouring
impossible (see Figure 1A). All patients were also imaged
with the HT MVCT scanner using coarse (6 mm inter-
slice distance) scan mode and the Planned Adaptive
Software (Accuray Inc. Sunnyvale, CA) was used to
merge MVCT information with kVCT image data to
create hybrid image sets with 3 mm inter-slice spacing
automatically interpolated from 6 mm slice MVCT data.
The HT MVCT scanner has a field of view of 40 cm,
so the area outside the MVCT imaging diameter was
filled with kVCT data for the purposes of dose calcula-
tion. The hybrid image sets were then transferred to Pin-
nacle treatment planning software (TPS) version 8.0 m
(Philips Healthcare, Andover, MA) for contouring by ra-
diation oncologists. MVCT studies were also transferred
to the Pinnacle TPS and the contours drawn on the hy-
brid image sets were transferred to the separate kVCT
and MVCT studies. This procedure provided the possi-
bility for unambiguous organ contouring but required
several steps of data transfer. The slice spacing in the
kVCT and hybrid image plans was 3 and 6 mm in the
MVCT image plans. The different energies of radiation
used in kVCT and MVCT imaging results in different
interactions of x-rays with materials therefore different
electron calibration curves must be used to convert
image Hounsfield unit (HU) values to electron density.
The kVCT image value to density table (IVDT) was used
for kVCT images and the MVCT IVDT was used for hy-
brid and MVCT images.
HT treatment plans were calculated using the Tomotherapy
Planning Station software version 3.2 (Accuray Inc.
Sunnyvale, CA) which utilizes a proprietary inverse
planning optimization algorithm [13,14]. The dose dis-
tribution is calculated based on the prescription dose to
the target, region of interest (ROI) constraints, and set-
tings specific to the HT system such as modulation fac-
tor and pitch. The modulation factor (MF) is defined as
the ratio between the greatest and the average (exclud-
ing closed leaves) beamlet fluence. Increasing the MF
gives the software more control over optimization but
requires a slower gantry rotation period, resulting in a
longer treatment time. The pitch value is the ratio be-
tween couch distance traveled per gantry rotation and
the field width. Increasing the pitch value reduces over-
lap of beams from subsequent rotations.
To compare the effects of employing different treat-
ment planning images, three image sets for each patient
were created: kVCT images alone, hybrid kVCT/MVCT
images, and MVCT images alone. The three image sets
and respective contours for each patient were trans-
ferred from the Pinnacle TPS to the Planning Station via
the DICOM RT protocol. All plans were optimized using
Figure 1 Comparison of A) kVCT and B) hybrid kVCT/MVCT image sets. The addition of MVCT data greatly reduces imaging artifacts.
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values [15]. Treatment optimization time was also kept
constant at 200 iterations. The normal dose grid option
was used with calculation grid voxels of 4.6 × 4.6 ×
3 mm3 used in kVCT and hybrid image plans. The cal-
culation grid voxels were 3.1 × 3.1 × 6 mm3 in the
MVCT image plans. The calculated dose distributions
for each image set were investigated and a comparison
of the dose distributions in the transverse plane for pa-
tient 2 is shown in Figure 2. The resulting dose volume
histograms (DVH) for each treatment plan were ana-
lyzed to determine the success of avoiding critical struc-
tures such as the bladder and rectum and delivering the
prescribed dose to the planning target volume (PTV).
Calculated doses to the bladder and rectum at volumes
of 5%, 10%, 25%, 35%, and 50% and doses to the PTV at
volumes of 1% (maximum dose to PTV) and 99% (mini-
mum dose to PTV) were analyzed for the calculated
treatment plans for each patient. Unlike the kVCT im-
ages, the patient MVCT studies did not image the entire
patient volume therefore there were portions of the
anatomy that were not imaged. Thus we also calculated
the absolute volumes that corresponded to 5%, 10%,
25%, 35%, and 50% of the bladder and rectum volume in
the MVCT studies for each patient and the doses to
these volumes were found in the kVCT and hybrid
image plans in order to properly compare the treatmentFigure 2 Calculated dose distribution of plans based on A) kVCT, B) Mplans. The entire PTV volume was imaged in all three
treatment plans therefore there was no need to calculate
absolute volumes to compare dose. These data were ob-
tained from the cumulative relative DVH for each treat-
ment plan.
Measurement in water phantom
To compare the effect of using different treatment
planning images on treatment delivery, simulations
were conducted using a water tank phantom fit with
two hip prostheses (DePuy Orthopaedics Inc, Warsaw,
IN). The prostheses had stems made of porous coated
titanium and cups made of a reflection titanium
shell, an ultra-high molecular weight polyethylene
(UHWMPE) liner and a cobalt-chromium (CoCr) head.
The prostheses were secured in the water tank phan-
tom at distances and orientations that simulated patient
anatomy.
The water tank phantom was imaged both on a kVCT
scanner and the HT MVCT unit. To correct for the arti-
facts present in the kVCT scan, the O-MAR reconstruc-
tion algorithm was applied, which greatly improved the
image quality as shown in (Figure 3A,B). The DICOM
sets for both the original kVCT scan and the same scan
with the O-MAR correction applied were transferred to
the Tomotherapy TPS as two separate “patients”. The
PTV, rectum, and bladder were contoured as threeVCT and C) hybrid kVCT/MVCT image sets.
Figure 3 Image sets of water tank with hip prostheses. Comparison of A) original kVCT, B) O-MAR corrected kVCT, C) kVCT/MVCT hybrid, and
D) MVCT images of the phantom with the hip prostheses inserted.
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for each in the coarse, normal, and fine modes (6, 4, and
2 mm inter-slice spacing, respectively). In total eleven
phantom image sets were created: kVCT alone with and
without O-MAR applied, MVCT alone with spacing of
2, 4, and 6 mm between slices, and hybrid kVCT/MVCT
images created with each of the three MVCT image
options for both the original kVCT and the kVCT with
O-MAR artifact correction. The image sets were trans-
ferred to Pinnacle via the DICOM RT protocol for con-
touring. The contours of the PTV, bladder and rectum
were then copied on to each of the hybrid and MVCT
image sets and exported to the Tomotherapy planning
station. Because there was no difference between the
MVCT scans for the corrected or original patient, only
three MVCT studies were used for planning. Pinnacle
transfers contours between image sets with different
inter-slice spacing by autocontouring the 3D shape
enclosed by the original contours and applying the
resulting contours on a specific slice. All plans were cal-
culated using the same dose prescription and region
of interest constraints. The calculation grid voxels were
3.1 × 3.1 × 6 mm3, 3.1 × 3.1 × 4 mm3, and 3.1 × 3.1 ×
2 mm3 in the MVCT coarse, normal, and fine image
plans, respectively. The altered density matrices employed
by plans based on different images affect both the final
dose calculation accuracy and cause the optimizer to
change the planned fluence. Therefore each of the
phantom plans was recalculated on the coarse hybrid
image created with the OMAR correction applied using
the Tomotherapy Planned Adaptive software. The dif-
ference between this verification plan and the original
plan is due to the density matrices, and the deviations
between verification plans is caused by planned fluence
changing for each plan.The procedure “to treat” the phantom was designed to
mimic patient treatment. The phantom was placed on the
HT couch and aligned with the laser positions specified
for treatment. The phantom was scanned using the HT
MVCT unit, the image was registered with the treatment
planning study and positioning correction shifts were ap-
plied if necessary. The treatment was performed and a
dose measurement was taken with a pinpoint ion chamber
(Wellhöfer, Model CC01, 0.01 cm3, Uppsala, Sweden) at a
point corresponding to the center of the PTV to compare
measured and calculated doses. This process was per-
formed for each of the 11 treatment plans.
To evaluate the influence of the presence of high dens-
ity material, a kVCT image of the phantom without the
hip prostheses was taken. Three MVCT scans, using the
coarse, normal and fine slice widths were also taken, and
a hybrid image set using each width was created. Using
the same contours, dose prescription and constraints, a
plan was created for each image set and dose measure-
ments performed.
Results
The results from the patient treatment plans obtained
with the same optimization procedure for three types of
image sets are shown in Table 1. Generally speaking, the
doses calculated in treatment plans using MVCT images
were higher than the doses calculated in the kVCT and
hybrid image treatment plans. The biggest difference
noted was in terms of dose to bladder. The calculated
D35 (dose to 35% of the volume) in the bladder for pa-
tients 1 and 3 differed by −3.2% and 1.2% for MVCT
and by 2.7% and 0.3% for hybrid image plans compared
to the calculated dose in the kVCT image plans. Mean
planned D35 in the rectum was within 2% of the kVCT
plan dose in both the MVCT and hybrid image plans for
Table 1 Calculated patient doses delivered to regions of interest for kVCT, MVCT and hybrid plans
Patient 1 Patient 2 Patient 3
Organ kVCT MVCT Hybrid kVCT MVCT Hybrid kVCT MVCT Hybrid
D5MVCT
B 67.1 63.7 67.6 81.8 77.2 80.9 78.6 80.3 78.7
R 76.0 75.6 75.3 65.0 70.5 70.9 77.6 81.2 77.7
D10MVCT
B 62.5 60.8 62.3 75.1 75.6 75.3 77.0 77.1 77.1
R 69.0 70.3 68.5 59.1 64.1 64.4 77.4 80.6 77.5
D25MVCT
B 48.1 48.4 48.4 50.7 57.1 55.6 67.8 67.8 68.1
R 51.4 51.7 51.7 45.2 48.4 50.0 74.8 72.0 74.9
D35MVCT
B 41.2 39.9 42.3 39.4 49.0 46.0 58.8 59.5 59.0
R 43.5 42.7 44.0 37.5 41.5 40.1 69.5 63.5 69.4
D50MVCT
B 30.9 33.0 31.9 25.4 37.3 34.2 48.1 47.2 48.1
R 35.7 33.0 36.1 31.9 35.1 34.2 59.2 45.2 59.5
D99 P 72.2 72.8 72.2 74.2 73.7 74.6 71.9 73.8 71.8
D1 P 83.6 81.4 83.5 89.1 82.6 85.0 79.6 85.1 79.7
Doses to volumes of the planning target volume (PTV), bladder and rectum for treatment plans using original kVCT, MVCT, and hybrid image sets are shown.
B = bladder, R = rectum, and P = PTV. DnMVCT is the dose delivered to the absolute volume corresponding to n% of the ROI in the MVCT base plans.
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MVCT plan for patient 3 had a dose 8.6% lower than
the kVCT plan. As larger volumes of the bladder and
rectum were considered, the absolute difference in dose
between the MVCT and kVCT plans increased. The
same trend followed for hybrid plans compared to kVCT
plans but to a lesser extent. Patient 2 showed the largest
calculated differences in rectum and bladder dose for
MVCT and hybrid plans compared to kVCT. Bladder
dose difference of 47% and a rectal dose difference of
10% were seen in the MVCT plan for patient 2 at D50.
The hybrid plans for patient 2 showed smaller differ-
ences of 35% and 7% at D50 for the bladder and rectum,
respectively. Calculated doses to the PTV were similar
in the three treatment plans calculated for each patient.
For the three patients, the greatest difference in planned
D99 (dose to 99% of the volume) in the PTV compared
to kVCT plans was 2.6% and 0.5% for MVCT and hybrid
plans, respectively.Table 2 Results of radiation delivery to the water tank phant









kVCT 2.01 2.03 −1.00 1.99
HybridCoarse 2.01 2.04 −1.14 2.02
HybridNormal 2.01 2.04 −1.06 2.00
HybridFine 2.01 2.03 −1.18 2.02
MV C 1.89 2.01 −6.21 1.91
MV N 1.91 2.03 −6.00 1.92
MV F 1.91 2.02 −5.73 1.91
Delivered dose was measured with a pinpoint ion chamber at a point correspondin
that point.The phantom “treatment” results are shown in Table 2.
The kVCT plan with the O-MAR correction applied
showed better agreement between the measured and cal-
culated dose than the original image set, with a differ-
ence of −1.91% compared to −3.31%. However, both of
these values were worse than the agreement with the
hips removed, which was a difference of −1.0% for the
kVCT plan. The measured doses for the MVCT plans
were always lower than the calculated dose, by between
−6.21% and −5.04% with and without the hip prostheses
inserted. The best agreement was for the hybrid plans,
which had differences ranging from −1.21% to −0.72%
with the hips inserted and from −1.18% to −1.06% with-
out them.
Table 3 contains the percent difference in dose to vol-
umes of the bladder, rectum and PTV between the ori-
ginal plans and the recalculated verification dose for the
kVCT and OMAR corrected kVCT image sets of the
water tank phantom. The verification dose was higherom











2.03 −1.91 1.97 2.04 −3.31
2.03 −0.72 2.01 2.03 −1.21
2.02 −0.92 2.02 2.03 −0.75




g to the center of the PTV and compared with the calculated dose at
Table 3 Percent difference between planned and
verification dose for kVCT and OMAR corrected kVCT
images
Image set kVCT OMAR corrected kVCT
Organ Bladder Rectum PTV Bladder Rectum PTV
D5 1.23 −0.20 0.95 0.19
D10 1.03 −0.57 0.87 0.12
D25 0.86 −0.51 0.47 0.05
D35 0.87 −0.06 0.61 0.33
D50 0.76 −0.05 0.76 0.43
D1 1.38 0.86
D99 −0.77 0.08
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OMAR image set and for the bladder and dose to 1% of
the PTV in the uncorrected kVCT plan. The differences
were larger for the kVCT plan without the OMAR cor-
rection, except for the D35 and D50 of the rectum.
Discussion
We have presented treatment planning results for plans
calculated from patient data and measurements of treat-
ment delivery using real hip prostheses within a water
tank phantom designed to simulate patient anatomy.
Our results explored the accuracy of using different
sources of treatment planning images to treat patients
with bilateral hip prostheses.
As follows from Table 1, there are differences in calcu-
lated dose between patient treatment plans depending
on the source of treatment planning images. Contours
and HT optimization settings were kept constant within
patients, so the differences in calculated dose between
plans were designed to be only the result of differences
in the images used for treatment planning. Largest dif-
ference was observed between dose to D50MVCT =
57 cm3 of the patient 2 bladder (Table 1). This patient
had the strongest artifacts from his hip prostheses
(Figure 1) resulting in a low effective density in this re-
gion. We found that the hybrid plans had the best agree-
ment with the measured dose verified in phantom with
or without the presence of the hip prostheses. In
addition, recalculating kVCT phantom plans using the
hybrid image set showed disparities on the order of the
differences between the kVCT and hybrid plans. Due to
the simplicity of the phantom geometry, the differences
between plans were small; they could be larger for the
more complicated patient anatomy.
Previous research has aimed at improving dose calcu-
lation accuracy in presence of high atomic number ma-
terials such as titanium hip prostheses using MVCT
imaging. Hecox et al. investigated the accuracy of the
HT dose calculation algorithm in the presence of asingle hip prosthesis [9]. Similar to our results they
found that there was very good agreement between cal-
culated and delivered dose to the PTV. The accuracy of
HT dose calculation is better in the presence of a single
hip prosthesis. This is due to the increased freedom that
the treatment planning software has to optimize the
treatment plan. In the case of bilateral hip prostheses
the software is very constrained because it tries to limit
the number of beams that pass directly through the
highly dense prostheses. The prostheses surround the
target therefore there are only limited directions from
which radiation can be effectively delivered. Our studies
with the water tank phantom without the prostheses
showed very good agreement between the measured and
calculated dose for the plans based on the kVCT and the
hybrid kVCT/MVCT image sets. This suggests that the
phantom design is valid and that dose can be accurately
calculated in water phantom.
A number of other factors may have also been respon-
sible for the differences in measured dose observed dur-
ing phantom irradiation. These include: artifacts present
in the kVCT images, interpolation between slices in the
hybrid image sets, use of different IVDT depending on
the source of treatment planning images, the limited
field of view of MVCT images, and uncertainty in the
positioning of the ion chamber during measurement
with respect to the image voxel where the calculated
dose was reported. Metal artifacts in kVCT images alter
image density values, especially in the target area for
prostate cancer radiation therapy. Image density, quanti-
fied in HU is the basis for treatment planning and calcu-
lating the dose delivered to specific areas. The artifacts
present in kVCT images created artificial regions of high
and low density that did not accurately reflect true dens-
ity values in the phantom. Our results show that the
presence of metal artifacts did not have a significant ef-
fect on dose delivery to the PTV, rectum or bladder. It
appears that metal artifacts are not the primary cause of
treatment dose differences, perhaps due to the helical
nature of HT radiation delivery.
As previously mentioned, hybrid kVCT/MVCT image
sets were produced using the HT Planned Adaptive soft-
ware. The 2, 4, and 6 mm slices of the MVCT studies
were modified to 3 mm slices by interpolation to corres-
pond with the slice spacing in the kVCT study. De-
creased inter-slice spacing reduces the amount of
interpolation necessary to create hybrid image sets and
should result in image sets that more accurately reflect
patient anatomy. However, the difference in the agree-
ment between the measured and calculated dose for the
coarse, normal and fine hybrid plans was minimal in our
experiment, so the coarse setting would be the best to
use, as it takes less time to perform the scan and delivers
less radiation. Hybrid images have been shown to be
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accuracy to initial kVCT dose calculations [16]. This was
reflected in our study as the DVH for kVCT and hybrid
image plans were very similar and the calculated point
doses in the PTV were nearly identical.
Depending on the source of images used to calculate
treatment plans, different IVDT calibration curves were
used to convert image HU values to electron density for
treatment calculation. The two calibration curves are
similar at low HU values from −1000 to 0 (equal to the
densities of air and water, respectively) but differ signifi-
cantly as greater HU values are considered. The hybrid
image sets were comprised mostly of MVCT data; how-
ever there were portions of the images that were supple-
mented with kVCT data because the water tank
phantom was larger than the 40 cm MVCT imaging
diameter. Therefore, in the hybrid image treatment plans
the electron density of the kVCT portions of the image
may not have been accurately accounted for. In our
study, the use of different IVDT calibration curves did
not have a significant effect on dose delivery due to the
relatively low densities of the materials used in the water
tank phantom. The observed HU values of the water
tank and water in the kVCT image were approximately
zero so similar IVDT values were calculated compared
to areas calculated with the MVCT calibration curve.
The lateral edges of the tank were the only volume sup-
plemented by the kVCT data, but there was much less
fluence delivered to the PTV through these areas. This
was because the smaller depth of the water relative to
the width of the tank caused the optimizer to favour an-
terior and posterior gantry angles. However, the effects
of using different calibration curves are expected to be
more significant in patient treatment plans due to the
greater density of muscle, bone and other tissue as well
as greater variation in anatomy compared to the water
tank phantom. If a large patient volume must be supple-
mented with kVCT data then there is the potential for
large differences in IVDT which would have an effect on
treatment delivery.
A limitation of using “MVCT only” for treatment plan
calculations is the limited field of view of these images.
MVCT allows for the clear visualization of pelvic anat-
omy in the presence of hip prostheses but large patients
cannot be imaged entirely as in kVCT. In our study, the
phantom was larger than the 40 cm imaging diameter of
the HT MVCT unit therefore there were parts of the
phantom that were not imaged. These non-imaged areas
were not taken into account during treatment calcula-
tion. This may have contributed to plans based on
MVCT images showing the largest dose differences
in the PTV. Radiation was absorbed when delivered
through the non-imaged areas, resulting in less dose
reaching the target. This would explain why the plansbased on MVCT images consistently had a difference
between the measured and calculated dose of −5%
to −6%, independently of whether or not the hips were
inserted. Ruchala et al. have explored different algo-
rithms to improve limited field of view images such as
MVCT using planning CT data [17], similar to the
method used by the Planned Adaptive Software to create
hybrid image sets. The soft tissue contrast obtained in
MVCT images is sufficient for contouring the prostate,
bladder, and rectum; allowing for dose delivery verifica-
tion with the Planned Adaptive software and plan adap-
tation if anatomic changes are clinically significant [18].
Investigation of different algorithms may prove helpful
in improving the accuracy of hybrid images created from
limited field of view MVCT images. Treatment plans
should not be based on MVCT images alone for patients
with significant volumes outside the 40 cm imaging
region.
The factor that seems to have the largest impact on
measured dose differences during phantom treatment is
uncertainty in the positioning of the ion chamber. Regis-
tration of the phantom was performed prior to treat-
ment in an effort to ensure accurate positioning of the
ion chamber in specific voxels, however due to the rela-
tively large size of the ion chamber relative to individual
voxels there was potential for dislocation. This is signifi-
cant due to the large dose differences that can exist be-
tween adjacent calculation voxels, especially in high dose
gradient regions such as the bladder and rectum. For ex-
ample, in the hybrid image plans the calculated dose im-
mediately anterior and posterior of the expected point of
measurement are on average approximately 6% higher
and 6% lower respectively. This difference of 6% is
roughly the observed experimental difference between
calculated and measured dose. From this, it is difficult to
determine if the true source of differences in measured
dose, especially in the bladder and rectum due to dose
inhomogeneity in these regions. The dose distribution
calculated for the PTV is much more homogeneous and
therefore it is expected that the ion chamber measure-
ments in the PTV are much more accurate. The relative
dose differences between adjacent voxels in the PTV are
much smaller, typically < 1% and as such, the positioning
of the ion chamber will not have a large effect on mea-
sured dose.
An emerging strategy for dealing with bilateral hip
prostheses is the use of MR-only simulation [19,20].
Conceptually the work flow would be similar to incorp-
orating MVCT through image fusion with the kVCT
with similar concerns such as variable patient anatomy
between scans and image fusion accuracy. Rosewall
et al. found less inter-observer variability and no evi-
dence of geometric distortion in an inter-observer study
of prostate delineation on CT alone versus hybrid CT
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thesis but did not describe dosimetric results [21].
Conclusion
In order to minimize the effect of the artifacts caused by
high density metal hip implants in the prostate cancer
patients, the following procedure is recommended: (i)
a kVCT scan, followed by (ii) an MVCT scan using the
coarse 6 mm slice spacing, and (iii) creation of a hybrid
image set. MVCT image will provide better visualization
of patient anatomy and hybrid kV/MVCT study enables
more accurate calculations using updated MVCT rela-
tive electron density calibration. Ideally the kVCT and
MVCT studies should be acquired in close proximity in
order to minimize temporal variations in patient anat-
omy. If MVCT image fusion is not available, kVCT
correction algorithms still provide improved dose calcu-
lation compared to uncorrected kVCT.
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